Latest News & Updates

Breaking News

  • 7 minutes ago

  • Simantini Singh Deo

Mesoblast Partners With PPMD To Support Enrollment For FDA-Cleared Registrational DMD Trial
Breaking News
PathAI And MedStar Team Up To Bring AI-Powered Digital Pathology Across Multi-Site Network

Simantini Singh Deo

Other trending news you may like to read

Mesoblast Partners With PPMD To Support Enrollment For FDA-Cleared Registrational DMD Trial

Mesoblast receives FDA IND clearance for registrational trial of Ryoncil in Duchenne muscular dystrophy and partners with PPMD to support patient enrollment and study execution.

Simantini Singh Deo

Pharma Now

PathAI And MedStar Team Up To Bring AI-Powered Digital Pathology Across Multi-Site Network

PathAI partners with MedStar Health to deploy AISight Dx digital pathology platform and AI algorithms across its network, enhancing diagnostic accuracy, workflow efficiency, and collaboration.

Simantini Singh Deo

Pharma Now

Sanofi Leader Says Phase 2 Findings Support Lunsekimig’s Potential As A New Treatment Option For Chronic Respiratory Conditions

Sanofi reports positive Phase 2 results for lunsekimig in asthma and chronic respiratory diseases, showing reduced exacerbations, improved lung function, and consistent safety profile.

Simantini Singh Deo

Pharma Now

Merakris Reports Positive Results For MTX-001 In Venous Leg Ulcers Ahead Of Late-Stage Trials

Merakris Therapeutics reports positive Phase II and real-world data for MTX-001 in venous leg ulcers, showing ulcer size reduction and supporting progression toward late-stage clinical trials.

Simantini Singh Deo

Pharma Now